A research group has uncovered important details about how platelet-activating factor (PAF)—a powerful molecule involved in ...

A research group led by Dr. Keisuke Obara, Dr. Kento Yoshioka, and Professor Yoshio Tanaka from the Department of Chemical ...

Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...

THN391 has the potential to be a first-in-class antibody that can block fibrin-mediated neuroinflammation without affecting coagulation pathways, and recently completed a phase 1ba trial in ...

Integrated metabolome and transcriptome analysis reveals salicylic acid and flavonoid pathways’ key roles in cabbage’s defense responses to Xanthomonas campestris pv. campestris ...

Viscoelastic assays detect coagulation abnormalities that do not always appear on traditional coagulation tests in patients with ICH. It is unclear whether the results of these studies correlate with ...

Lastly, lower levels of TFPI were associated with progression. This indicates that there is less inhibition of the extrinsic coagulation cascade in patients with AF progression due to reduced TFPI, ...